Trial intelligence / Profile preview

Cisplatin in BRCA1 Positive Breast Cancer

NCT01630226Phase 2Unknown

Sponsor
Pomeranian Medical University in Szczecin
Start
Jun 2007
Primary completion
Dec 2013
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of cisplatin in breast cancer, sponsored by Pomeranian Medical University in Szczecin. Status: unknown.

02

Drugs

cisplatin
03

Conditions

breast cancer

Beyond the preview

Go deeper on NCT01630226.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01630226.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call